The Nomination and Remuneration Committee (NRC) of yatharth hospital approved the grant of 250,000 employee stock options to eligible staff members on August 10, 2026. The move aligns with the company’s strategy to retain talent through equity-based incentives under the Yatharth Hospital & Trauma Care Services Employee Stock Option Scheme - 2024.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III and SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. The NRC meeting commenced at 11:15 AM IST and concluded at 11:50 AM IST.

Key Terms of the Grant

The granted options are convertible into an equal number of equity shares with a face value of ₹10 each. The exercise price for these options is set at ₹10 per option, equivalent to the face value of the company’s equity shares. This pricing structure ensures that the exercise price does not fall below the statutory minimum while providing a clear cost basis for employees upon vesting.

Vesting and Exercise Conditions

Options will begin vesting one year from the grant date, extending up to a maximum of four years, as determined by the Committee in the Grant Letter. In cases of death or permanent disability of a grantee, the minimum one-year vesting period is waived, and options vest immediately in accordance with SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021.

Once vested, employees may exercise their options wholly or partially within two years from the respective vesting date. The Committee retains discretion to open specific exercise windows during this period. The scheme will be implemented via fresh allotment of shares directly to eligible employees.

What the Numbers Show

The grant of 250,000 options at par value (₹10) indicates a conservative approach to dilution, likely targeting broad-based employee retention rather than high-value executive compensation. With full exercise potential leading to 250,000 new shares, the impact on existing shareholders’ equity will depend on actual vesting rates and future share price movements relative to the fixed exercise price.

Yatharth Hospital & Trauma Care Services Ltd company name will host an investor meeting on August 12, 2026, providing shareholders and market participants with a direct channel to engage with management. The session is designed to offer transparency into the healthcare provider’s operational status and strategic priorities, allowing investors to assess the company's trajectory in a competitive sector.

The announcement was made via exchange filings, identifying the company by its Scrip Code 543950 and ISIN INE0JO301016. The investor meet serves as a key communication tool for listed entities to address stakeholder queries and reinforce confidence in corporate governance and business execution.

Operational Footprint

The company maintains a diversified geographic presence across key regions in India, with facilities located in:

This multi-state footprint underscores the organization’s expansion strategy beyond its primary base in the National Capital Region, extending services into central India through its Orchha facility.

What This Means for Investors

The upcoming meeting offers a structured opportunity for investors to gain insights into Yatharth Hospital’s growth drivers and risk management frameworks. For stakeholders monitoring the healthcare segment, such engagements are critical for validating long-term value propositions and understanding capital allocation plans. The specific agenda for the August 12 session has not been detailed in the initial filing, but it is expected to cover general business updates and address questions from the investment community.